메뉴 건너뛰기




Volumn 51, Issue 1, 2014, Pages 154-156

Use of ketamine in a newborn with refractory status epilepticus: A case report

Author keywords

cortical malformations; ketamine; newborn; refractory status epilepticus

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; KETAMINE; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; ANTICONVULSIVE AGENT;

EID: 84902509346     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2014.03.006     Document Type: Article
Times cited : (18)

References (15)
  • 1
    • 38649086112 scopus 로고    scopus 로고
    • A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation
    • B.S. Martin, and J. Kapur A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation Epilepsia 49 2008 248 255
    • (2008) Epilepsia , vol.49 , pp. 248-255
    • Martin, B.S.1    Kapur, J.2
  • 2
    • 43449091883 scopus 로고    scopus 로고
    • Treatment of refractory status epilepticus: Literature review and a proposed protocol
    • N.S. Abend, and D.J. Dlugos Treatment of refractory status epilepticus: literature review and a proposed protocol Pediatr Neurol 38 2008 377 390
    • (2008) Pediatr Neurol , vol.38 , pp. 377-390
    • Abend, N.S.1    Dlugos, D.J.2
  • 3
    • 0036128487 scopus 로고    scopus 로고
    • Refractory status epilepticus: Frequency, risk factors, and impact on outcome
    • S.A. Mayer, J. Claassen, and J. Lokin et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome Arch Neurol 59 2002 205 210
    • (2002) Arch Neurol , vol.59 , pp. 205-210
    • Mayer, S.A.1    Claassen, J.2    Lokin, J.3
  • 4
    • 84860886569 scopus 로고    scopus 로고
    • Early ketamine to treat refractory status epilepticus
    • A.H. Kramer Early ketamine to treat refractory status epilepticus Neurocrit Care 16 2012 299 305
    • (2012) Neurocrit Care , vol.16 , pp. 299-305
    • Kramer, A.H.1
  • 5
    • 84871267087 scopus 로고    scopus 로고
    • Efficacy and safety of ketamine in refractory status epilepticus in children
    • A. Rosati, M. L'Erario, and L. Ilvento et al. Efficacy and safety of ketamine in refractory status epilepticus in children Neurology 79 2012 2355 2358
    • (2012) Neurology , vol.79 , pp. 2355-2358
    • Rosati, A.1    L'Erario, M.2    Ilvento, L.3
  • 6
    • 40449086100 scopus 로고    scopus 로고
    • Bumetanide enhances phenobarbital efficacy in a neonatal seizure model
    • V.I. Dzhala, A.C. Brumback, and K.J. Staley Bumetanide enhances phenobarbital efficacy in a neonatal seizure model Ann Neurol 63 2008 222 235
    • (2008) Ann Neurol , vol.63 , pp. 222-235
    • Dzhala, V.I.1    Brumback, A.C.2    Staley, K.J.3
  • 7
    • 20444388639 scopus 로고    scopus 로고
    • Status epilepticus increases the intracellular accumulation of GABAA receptors
    • H.P. Goodkin, J.L. Yeh, and J. Kapur Status epilepticus increases the intracellular accumulation of GABAA receptors J Neurosci 25 2005 5511 5520
    • (2005) J Neurosci , vol.25 , pp. 5511-5520
    • Goodkin, H.P.1    Yeh, J.L.2    Kapur, J.3
  • 8
    • 53249128949 scopus 로고    scopus 로고
    • GABA(A) receptor properties in catastrophic infantile epilepsy
    • L.A. Jansen, L.D. Peugh, and J.G. Ojemann GABA(A) receptor properties in catastrophic infantile epilepsy Epilepsy Res 81 2008 188 197
    • (2008) Epilepsy Res , vol.81 , pp. 188-197
    • Jansen, L.A.1    Peugh, L.D.2    Ojemann, J.G.3
  • 9
    • 0033597091 scopus 로고    scopus 로고
    • N-methyl-D-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat
    • A.M. Mazarati, and C.G. Wasterlain N-methyl-D-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat Neurosci Lett 265 1999 187 190
    • (1999) Neurosci Lett , vol.265 , pp. 187-190
    • Mazarati, A.M.1    Wasterlain, C.G.2
  • 10
    • 0025057211 scopus 로고
    • NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures
    • J. Kapur, and E.W. Lothman NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures Epilepsy Res 5 1990 103 111
    • (1990) Epilepsy Res , vol.5 , pp. 103-111
    • Kapur, J.1    Lothman, E.W.2
  • 11
    • 0028830749 scopus 로고
    • Neuroprotective effect of ketamine administered after status epilepticus onset
    • D.G. Fujikawa Neuroprotective effect of ketamine administered after status epilepticus onset Epilepsia 36 1995 186 195
    • (1995) Epilepsia , vol.36 , pp. 186-195
    • Fujikawa, D.G.1
  • 12
    • 84878437092 scopus 로고    scopus 로고
    • Ketamine use in the treatment of refractory status epilepticus
    • A.S. Synowiec, D.S. Singh, and V. Yenugadhati et al. Ketamine use in the treatment of refractory status epilepticus Epilepsy Res 105 2013 183 188
    • (2013) Epilepsy Res , vol.105 , pp. 183-188
    • Synowiec, A.S.1    Singh, D.S.2    Yenugadhati, V.3
  • 13
    • 84864651252 scopus 로고    scopus 로고
    • The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy
    • M. Ferlisi, and S. Shorvon The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy Brain 135 2012 2314 2328
    • (2012) Brain , vol.135 , pp. 2314-2328
    • Ferlisi, M.1    Shorvon, S.2
  • 14
    • 84902364799 scopus 로고    scopus 로고
    • NMDA antagonists for refractory seizures
    • Epub ahead of print
    • F.A. Zeiler, J. Teitelbaum, and L.M. Gillman et al. NMDA antagonists for refractory seizures Neurocrit Care 2014 Epub ahead of print
    • (2014) Neurocrit Care
    • Zeiler, F.A.1    Teitelbaum, J.2    Gillman, L.M.3
  • 15
    • 0141493917 scopus 로고    scopus 로고
    • Oral ketamine in paediatric non-convulsive status epilepticus
    • L.D. Mewasingh, T. Sékhara, and A. Aeby et al. Oral ketamine in paediatric non-convulsive status epilepticus Seizure 12 2003 483 489
    • (2003) Seizure , vol.12 , pp. 483-489
    • Mewasingh, L.D.1    Sékhara, T.2    Aeby, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.